These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23159262)

  • 21. Mental health and child developmental problems: the "not-so-new morbidity".
    Dreyer BP
    Acad Pediatr; 2009; 9(4):206-8. PubMed ID: 19608120
    [No Abstract]   [Full Text] [Related]  

  • 22. Bill paves the way for more birth defects research.
    Dove A
    Nat Med; 1998 Jun; 4(6):649. PubMed ID: 9623958
    [No Abstract]   [Full Text] [Related]  

  • 23. Application of data screening to drug exposure in large risk factor studies of birth defects.
    Louik C; Werler M; Anderka M; Mitchell AA
    Birth Defects Res A Clin Mol Teratol; 2015 Aug; 103(8):713-7. PubMed ID: 26259777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population and case-control surveillance in the search for environmental causes of birth defects.
    Oakley GP
    Public Health Rep; 1984; 99(5):465-8. PubMed ID: 6207556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention.
    Correa-Villaseñor A; Cragan J; Kucik J; O'Leary L; Siffel C; Williams L
    Birth Defects Res A Clin Mol Teratol; 2003 Sep; 67(9):617-24. PubMed ID: 14703783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating birth defects surveillance in maternal and child health at the state level.
    Klein Walker D
    Teratology; 2000; 61(1-2):4-8. PubMed ID: 10603196
    [No Abstract]   [Full Text] [Related]  

  • 27. Individuals With Disabilities Who Have Diabetes: Do We Have Targeted Interventions?
    Comer-HaGans D; Austin S; Ramamonjiarivelo Z
    Intellect Dev Disabil; 2016 Apr; 54(2):106-11. PubMed ID: 27028252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Centers for Disease Control program to prevent primary and secondary disabilities in the United States.
    Houk VN; Thacker SB
    Public Health Rep; 1989; 104(3):226-31. PubMed ID: 2471222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The co-occurrence of autism and birth defects: prevalence and risk in a population-based cohort.
    Schendel DE; Autry A; Wines R; Moore C
    Dev Med Child Neurol; 2009 Oct; 51(10):779-86. PubMed ID: 19416313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The promise and limitations of home visiting: implementing effective programs.
    Gomby DS
    Child Abuse Negl; 2007 Aug; 31(8):793-9. PubMed ID: 17822761
    [No Abstract]   [Full Text] [Related]  

  • 31. Public health approach to birth defects, developmental disabilities, and genetic conditions.
    Rasmussen SA; Moore CA
    Am J Med Genet C Semin Med Genet; 2004 Feb; 125C(1):1-3. PubMed ID: 14755427
    [No Abstract]   [Full Text] [Related]  

  • 32. Medical toxicology and public health-update on research and activities at the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
    Wang RY
    J Med Toxicol; 2008 Jun; 4(2):143-4. PubMed ID: 18570177
    [No Abstract]   [Full Text] [Related]  

  • 33. Birth defects surveillance: epidemiology, health services research, public health, and prevention.
    Kirby RS; Browne ML
    Birth Defects Res A Clin Mol Teratol; 2013 Oct; 97(10):617-8. PubMed ID: 24142497
    [No Abstract]   [Full Text] [Related]  

  • 34. Medical toxicology and public health - update on research and activities at the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
    Patel M; Belson M; Wang R; Schwartz M
    J Med Toxicol; 2006 Jun; 2(2):83-4. PubMed ID: 18072121
    [No Abstract]   [Full Text] [Related]  

  • 35. Medical toxicology and public health--update on research and activities at the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry.
    Schwartz M; Gorman SE
    J Med Toxicol; 2007 Sep; 3(3):139-40. PubMed ID: 18072150
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinician reviewers in birth defects surveillance programs: survey of the National Birth Defects Prevention Network.
    Lin AE; Forrester MB; Cunniff C; Higgins CA; Anderka M
    Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):781-6. PubMed ID: 17051528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Program evaluation and chronic diseases: methods, approaches, and implications for public health.
    Jack L; Mukhtar Q; Martin M; Rivera M; Lavinghouze SR; Jernigan J; Siegel PZ; Heath G; Murphy D
    Prev Chronic Dis; 2006 Jan; 3(1):A02. PubMed ID: 16356355
    [No Abstract]   [Full Text] [Related]  

  • 38. Development and implementation of the first national data quality standards for population-based birth defects surveillance programs in the United States.
    Anderka M; Mai CT; Romitti PA; Copeland G; Isenburg J; Feldkamp ML; Krikov S; Rickard R; Olney RS; Canfield MA; Stanton C; Mosley B; Kirby RS
    BMC Public Health; 2015 Sep; 15():925. PubMed ID: 26386816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hospitalizations of newborns with folate-sensitive birth defects before and after fortification of foods with folic acid.
    Robbins JM; Tilford JM; Bird TM; Cleves MA; Reading JA; Hobbs CA
    Pediatrics; 2006 Sep; 118(3):906-15. PubMed ID: 16950980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population-based birth defects surveillance data: The cornerstone of epidemiologic and health services research and disease prevention.
    Kirby RS; Browne ML
    Birth Defects Res A Clin Mol Teratol; 2015 Nov; 103(11):893-4. PubMed ID: 26470839
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.